Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

S100P-IN-1 is an inhibitor of S100 calcium-binding protein P (S100P).1 It inhibits the binding of S100P to its receptor, the receptor for advanced glycation end products (RAGE; IC50 = 22.7 nM). S100P-IN-1 (10 µM) selectively inhibits the invasion of BxPC-3 pancreatic cancer cells, which endogenously express S100P, over PANC-1 pancreatic cancer cells, which do not express S100P. It reduces tumor size and inhibits M2 polarization of tumor-associated macrophages in a subcutaneous murine Lewis lung carcinoma model at 10 mg/kg.2
WARNING This product is not for human or veterinary use.
1. Discovery of novel small molecule inhibitors of S100P with in vitro anti-
2. S100P facilitates LUAD progression via PKA/c-